Are Analysts Bullish about Natus Medical Incorporated (NASDAQ:BABY) after last week?

January 23, 2018 - By Stephen Andrade

 Are Analysts Bullish about Natus Medical Incorporated (NASDAQ:BABY) after last week?
Investors sentiment decreased to 0.76 in Q3 2017. Its down 0.41, from 1.17 in 2017Q2. It worsened, as 32 investors sold Natus Medical Incorporated shares while 70 reduced holdings. 20 funds opened positions while 58 raised stakes. 30.60 million shares or 0.12% more from 30.57 million shares in 2017Q2 were reported.
Hanson Doremus Invest Management stated it has 1,200 shares or 0.02% of all its holdings. Louisiana State Employees Retirement System reported 0.02% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY). Nationwide Fund Advsrs owns 0.05% invested in Natus Medical Incorporated (NASDAQ:BABY) for 319,481 shares. Stifel reported 315,096 shares. Us National Bank De owns 2,653 shares or 0% of their US portfolio. Advisory Services Networks Limited Liability Corp owns 248 shares or 0% of their US portfolio. Beddow Capital Mngmt reported 2.79% in Natus Medical Incorporated (NASDAQ:BABY). Alphamark Advsrs Ltd Liability invested in 26,170 shares. Benjamin F Edwards reported 2,732 shares. Moreover, Legal And General Group Inc Public Limited Com has 0% invested in Natus Medical Incorporated (NASDAQ:BABY) for 63,682 shares. Strs Ohio holds 0.02% of its portfolio in Natus Medical Incorporated (NASDAQ:BABY) for 110,000 shares. Wells Fargo & Communication Mn, a California-based fund reported 99,741 shares. Public Sector Pension Investment Board holds 0% or 20,810 shares. Olstein Cap Mngmt Lp has invested 0.42% in Natus Medical Incorporated (NASDAQ:BABY). Systematic Management L P holds 0.03% in Natus Medical Incorporated (NASDAQ:BABY) or 45,009 shares.

Since August 14, 2017, it had 0 buys, and 2 insider sales for $257,048 activity. GUNST ROBERT A also sold $154,748 worth of Natus Medical Incorporated (NASDAQ:BABY) on Thursday, September 14.

Natus Medical Incorporated (NASDAQ:BABY) Ratings Coverage

Among 5 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Natus Medical had 10 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Natus Medical Incorporated (NASDAQ:BABY) has “Buy” rating given on Monday, September 11 by Roth Capital. The rating was downgraded by Raymond James to “Mkt Perform” on Thursday, February 2. Roth Capital maintained Natus Medical Incorporated (NASDAQ:BABY) rating on Tuesday, April 5. Roth Capital has “Buy” rating and $39 target. The firm has “Buy” rating given on Tuesday, October 4 by Benchmark. The rating was maintained by Roth Capital with “Buy” on Friday, June 23. The company was maintained on Tuesday, January 12 by TH Capital. The stock of Natus Medical Incorporated (NASDAQ:BABY) earned “Hold” rating by William Blair on Monday, January 8. As per Tuesday, September 13, the company rating was upgraded by Raymond James. On Thursday, October 22 the stock rating was maintained by TH Capital with “Buy”. The company was maintained on Thursday, July 23 by TH Capital. Below is a list of Natus Medical Incorporated (NASDAQ:BABY) latest ratings and price target changes.

08/01/2018 Broker: William Blair Rating: Hold Downgrade
11/09/2017 Broker: Roth Capital Rating: Buy New Target: $44.0 Maintain

The stock increased 1.42% or $0.4 during the last trading session, reaching $28.65. About 259,373 shares traded. Natus Medical Incorporated (NASDAQ:BABY) has risen 4.38% since January 23, 2017 and is uptrending. It has underperformed by 12.32% the S&P500.

Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide. The company has market cap of $877.94 million. It offers services and products used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. It currently has negative earnings. The companyÂ’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.

More notable recent Natus Medical Incorporated (NASDAQ:BABY) news were published by: Streetinsider.com which released: “Form 8-K NATUS MEDICAL INC For: Jan 05” on January 05, 2018, also Gurufocus.com with their article: “Detailed Research: Economic Perspectives on Basic Energy Services, Intercept …” published on January 19, 2018, Globenewswire.com published: “Natus Medical to Hold 2017 Fourth Quarter Financial Results Conference Call on …” on January 17, 2018. More interesting news about Natus Medical Incorporated (NASDAQ:BABY) were released by: Fool.com and their article: “Why Natus Medical Inc Sank Lower Today” published on January 08, 2018 as well as Nasdaq.com‘s news article titled: “SMART Global Holdings, Natus Medical, Interactive Brokers Group, Renasant and …” with publication date: January 16, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.